Individual healthcare-seeking pathways for tuberculosis in Nigeria private sector during the COVID-19 pandemic

Background: Pre-COVID-19, individuals with TB in Nigeria were often underdiagnosed and untreated. Care for TB was mostly in the public sector while only 15% of new cases in 2019 were from the private sector. Reports highlighted challenges in accessing care in the private sector, which accounted for 67% of all initial care-seeking. Our study examined patients health seeking pathways for TB in Nigeria private sector, and explored any changes to care pathways during COVID, based on patients perspectives. Design/Methods: We conducted 180 cross-sectional surveys and 20 in-depth interviews with individuals having chest symptoms attending 18 high volume private clinics and hospitals in Kano and Lagos States. Questions focused on sociodemographic characteristics, health-seeking behavior and pathways to care during the COVID-19 periods. All surveys and interviews were conducted in May 2021. Results: Most participants were male (n=111, 62%), with average age of 37. Half (n=96, 53.4%) sought healthcare within a week of symptoms, while few (n=20, 11.1%) waited over 2 months. TB positive individuals had more health-seeking delays, and TB negative had more provider delays. On average, participants visited 2 providers in Kano and 1.69 in Lagos, with 61 (75%) in Kano and 48 (59%) in Lagos visiting other providers before the recruitment facility. Private providers were the initial encounters for most participants (n=60 or 66.7% in Kano, n-83 or 92.3% in Lagos). Most respondents (164 or 91%) experienced short-lived pandemic-related restrictions, particularly during the lockdowns, affecting access to transportation, and closed facilities. Conclusions: This study showed a few challenges in accessing TB healthcare in Nigeria, necessitating continued investment in healthcare infrastructure and resources, particularly in the private sector. Understanding the different care pathways and delays in care provides opportunities for targeted interventions to improve deployment of services closer to where patients first seek care.

The USAID-funded Strengthening Health Outcomes through the Private Sector (SHOPS) Plus 75 Nigeria project aimed to strengthen the private sector's capacity to detect and treat TB in 76 alignment with international standards and the national TB control plan. By training and 77 supporting over 2,900 private providers, including clinical providers, laboratories, community 78 pharmacists and proprietary patent medicine vendors (PPMVs) in Lagos and Kano States, the 79 project contributed to substantial increases in private sector TB notifications between 2017 and 80 2020 [30]. Our study utilized cross sectional surveys and qualitative interviews with individuals 81 with diagnosed and presumptive TB within the SHOPS Plus network in Kano and Lagos, to assess 82 how healthcare seeking and pathways may have changed in the private sector. This study aimed 83 to examine in Nigeria whether there were any long-lasting impacts of COVID on care-seeking 84 given that the apparent disruptions in care were relatively short-lived. 85 86 Conceptual framework 87 Our conceptual framework (Fig 1) is derived from existing literature [17,[31][32][33] and highlights 88 two main types of delays along pathways to TB care: health-seeking and health system delays. 89 Health-seeking delays refer to the time it takes from symptom onset to patients recognizing 90 their symptoms and seeking care from a healthcare provider. Health-seeking is influenced by 91 lack of TB knowledge, stigma, cost of seeking care, amongst other factors. Health system delays 92 occur once patients have sought care and can be further divided into provider delays and 93 treatment delays. Provider delays occur healthcare providers delay diagnosis due to low index 94 of suspicion of TB, limited diagnostic tools, misdiagnosis, or delays in making referrals, 95 conducting tests or transmitting results. Treatment delays occur when patients are diagnosed 96 with TB, but there is a delay in initiating treatment, due to a lack of medication or equipment, 97 insufficient staff, or poor communication between providers and patients. Diagnostic delays 98 refer to the time it takes from the onset of symptoms (individual-level) to the confirmation of 99 TB diagnosis (health-system level). Lack of knowledge of TB (symptoms, diagnosis and 100 treatment) is a common factor contributing to diagnostic delay [5]. 101 102 There is some consensus that delays should not exceed 2-4 weeks from onset of symptoms to 103 seek care, 3-7 days for testing (provider delay) using the current WHO-recommended TB 104 diagnostics, and 1-2 days for treatment initiation to optimise patient outcomes [34][35][36]. The 105 WHO considers as unethical any delay in treatment initiation in the presence of a positive 106 diagnosis or a strong presumption of TB [35]. 107 108 Previous studies conducted in Lagos [5] and rural Nigeria [7] found that health-seeking delays 109 were more common than provider delays, contributing more to overall total delay. The factors 110 associated with these delays can be categorized as individual-level (knowledge, attitudes, and 111 behaviours), or structural-level (relating to healthcare facilities, providers, doctors, etc.). 112 113 These delays can lead to 3 major gaps or missed opportunities in accessing TB care: Gap 1 114 includes those who never access TB testing, Gap 2 are those who access testing but are not 115 diagnosed, and Gap 3 includes those diagnosed but not treated. These gaps result in prolonged 116 illness, disease transmission, increased risk of drug-resistant TB, and death [1,32,33]. Studies 117 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

121
Study design, population and sampling 122 We conducted pathway analyses using mixed methods, to survey 180 individuals and conduct 123 20 in-depth interviews during the second COVID-19 wave in May 2021 (Appendix 1). This study 124 was part of a larger research project in 3 high burden countries. We previously published the 125 timelines of the COVID epi-curve, TB notifications and the timing of our data collection in 126 Nigeria [24]. Our study took place among individuals seeking TB care in 18 private facilities in 127 Kano and Lagos, the states with the highest TB burden and levels of private sector activity [30] Our analysis involved descriptive statistics, construction of care pathways and logistic 177 regressions. We weighted the data to address non-response and ensure the similarity between 178 responders and non-responders in terms of background characteristics [40,41]. We used 179 logistic regression with covariates to calculate non-response weight, and predictive 180 probabilities of survey response were calculated derived. Unweighted mean of probabilities 181 matched the 70% unweighted response rate in dataset. [3]. The non-response weight was 182 determined by inverting the predictive probabilities [41], resulting in a sum equal to the sample 183 size. 184 185 We used descriptive statistics to analyze demographic characteristics of non-responders, 186 considering both weighted and unweighted data. Health-seeking and health system delays 234 Half of the 180 participants (n=96, 53.4%) sought care with a provider within a week of noticing 235 their symptoms, with 17.8% seeking care within the first 2 days (Table 2). Only very few 236 patients (n=20, 11.1%) waited for 2 months and above before seeking care. 237 238 Health-seeking and provider delays were experienced more by participants diagnosed with TB 239 (38% and 43% Fig 2a), with 14% of them experiencing treatment delays. Participants from 240 Lagos (29%, Fig 2b) experienced more health-seeking delays. Provider and treatment delays 241 were more in Kano (40% and 10%) compared to in Lagos (28% and 4%). 242 243 Out of 180 participants, (n=71, 39%) had their sole provider encounter at the study recruitment 244 facilities (private clinics or hospitals), which included 3 individuals who had previously been 245 diagnosed at community outreaches ( Table 2). Fig 2c presents the number of participants and 246 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 20, 2023. ; https://doi.org/10.1101/2023.06.13.23291334 doi: medRxiv preprint the varying time delays at each provider encounter. Among 109 participants who visited other 247 providers before the recruitment facility, 55 had their initial encounter within a week, 25 248 waited 1-4 weeks, and 29 waited over a month. Out of the 33 who consulted two additional 249 providers, 8 waited 1-7 days from the first encounter, 16 waited 1-4 weeks, and 9 waited for 250 over a month. Among 8 who visited 3 providers, 4 waited 1-7 days following the second 251 encounter, 1 waited 1-4 weeks, and 3 waited for more than a month. Of the 2 who visited 4 252 providers, 1 waited 1-7 days, and the other waited 1-2 months. 253 254 At the recruitment facility, 96 of 180 participants waited 1-7days, 38 waited 1-4 weeks and 46 255 waited more than 1 month. Of those who waited more than a month, the majority were 256 individuals who had visited other providers. Delays between encounters increase with each 257 additional provider encounter, particularly with the 3 rd and 4 th encounters. Most TB patients 258 were initiated on treatment within 2 days of diagnosis (n=34, 75% in Kano; n=32, 73% in Lagos). 259 260 From the qualitative interviews, many participants, regardless of TB status, reported health-261 seeking delays as they waited until their symptoms became prolonged. Symptom minimisation 262 was a very common theme as most participants did not take coughing to be a serious health 263 issue, at first (Fig 3). Participants assumed that the cough would subside, and participants self-264 medicated. Some participants mentioned that they were also afraid of getting infected with or 265 being diagnosed with COVID-19. Provider delays were mostly due to misdiagnosis and delayed 266 referral to TB testing sites. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

291
The qualitative data (Fig 3, Appendix 5) shows many participants used a private provider first, 292 because these providers were more accessible and convenient, and public hospitals were 293 congested. In terms of choice of provider, this was either because of proximity, prior 294 relationship with provider, cost considerations or due to referral or contact tracing from 295 someone the participant knew. Several of those with more than one encounter said that the 296 medicine store was their first port of call. Many participants visited multiple providers as their 297 symptoms worsened, particularly those with TB. For participants diagnosed, once they were 298 told they had TB, several said they were placed on treatment on the same or next day. 299 Although the pathways to diagnosis were cumbersome for many, they expressed satisfaction 300 with the care they received afterwards. From the in-depth interviews, early on in the pandemic, participants were concerned about the 312 rising deaths due to COVID-19, which discouraged them from going to a clinic or hospital. 313 Participants didn't want to get infected, but more importantly, they didn't want to be forced to 314 take a diagnostic test for COVID-19, test positive, then have to quarantine, which was the 315 practice in many public hospitals at the time. A few participants said transport challenges 316 during the lockdown period hampered their access to care. Participants also mentioned 317 provider attitudes during the early phase of the pandemic as being fearful or unhelpful. 318 319 Determinants and factors influencing private sector use and number of encounters 320 We looked at predictors for two outcome variables -1) Choosing to use a private facility as their 321 first healthcare contact 2) Using more than one provider from symptom onset. We also present 322 the adjusted regression coefficient for the number of provider encounters. 323 324 When we looked at the predictors for participants choosing to use a private facility as their first 325 healthcare contact (Fig 5a) In our study of patient pathways within the private sector in two Nigerian states, we found that 334 individuals with chest symptoms experienced relatively short pathways. The study was 335 conducted in a unique context, differing from the typical urban areas in Nigeria. The sampled 336 providers belonged within the SHOPS Plus network, which provided extensive support to 337 private sector facilities, ensuring efficient referral systems, availability of laboratory equipment 338 and medications, and community engagement for case identification. Even within this context, 339 patients faced some health-seeking and provider delays. 340 341 Health-seeking and health system delays 342 Our investigation showed several challenges associated with health-seeking and provider 343 delays. However, once individuals with TB were identified and given a definitive diagnosis, their 344 experience with the healthcare provider was much more positive and timelier than their 345 experience before diagnosis, agreeing with several studies in Nigeria and other high burden 346 settings [32,38,42]. Of the 90 TB positive participants, majority (n=66, 73%) and all of the 347 qualitative interview participants were treated within 2 days of diagnosis, contributing to their 348 feelings of relief or gratitude, because they finally felt, 'seen' by the healthcare system. 349 350 Individual pathways and private sector use 351 Among the 180 participants and excluding the 71 who sought care first at the recruitment 352 facility, the majority (74 out of 109) initially sought care in private facilities. Some studies in 353 Nigeria and in similar high burden TB countries have found that patients seek care first in drug 354 stores or with traditional healers before clinics or hospitals [5,7,[43][44][45], particularly if they 355 were 'only' coughing [44,46]. 356 357 In our sample of networked providers, pharmacies and medicine vendors had higher rates of 358 providing or referring patients for TB testing and treatment, while the private hospitals and 359 clinics provided appropriate care for every patient who visited them. This was due to the 360 support this network of providers received, and the fact that most of the drug stores in our 361 sample were located close to the private clinics and hospitals in the same network. Few studies 362 have looked at the differences in referrals between different types of private providers; 363 however, studies in Nigeria and in similar settings show that case notifications and referrals for 364 TB care from the private sector has been historically very low and in need of intervention [42-365 44, 47-49]. The SHOPS Plus project, in collaboration with other stakeholders in Nigeria, have 366 implemented several strategies to strengthen linkages between the private sector and the 367 public TB delivery system [50]. 368 369 Several studies found that individuals with chest symptoms are very likely to minimise symptoms 370 like cough or fever [38,[51][52][53]. Similar results have been reported in other high-burden TB 371 settings where symptoms like weight loss were associated with faster care-seeking, in 372 comparison to cough and fever which were perceived to be 'normal' [7,51,52,54]. In some 373 settings, fever or headaches have been found to shorten delays [55][56][57]. 374 375 In charting patient pathways, our results show that all the patients who chose a private hospital 376 (including recruitment facility) as their first or second provider did not use an additional 377 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 20, 2023. provider. This was likely influenced by the fact that our recruitment facilities, which were 378 supported sites, represented the first facility for 71 (40%) of all participants. We also found a 379 similar pattern among patients who used a private hospital as second provider -of not going to 380 another provider. These findings agree with studies from several high burden TB countries, 381 where hospitals, in public and private sector, missed diagnosing TB patients [49,[58][59][60] and yet the responsibility for being diagnosed rests mostly on the patient, just like before the 395 pandemic [38]. Our findings agree with other studies showing TB positive participants face 396 longer diagnostic delays [32,33,38,63,64], often due to lack of access to a diagnostic test [32]. 397 398

Determinants of private sector use and numbers of providers 399
Our logistic regressions identified factors influencing private sector use and total number of 400 providers encountered within the context of our study. Our participants were all recruited 401 within a network of dedicated private providers in Kano and Lagos, making them distinct from 402 the general population in terms of their inclination and capacity to utilize private healthcare. 403 Participants in Lagos State were more likely to use the private sector first (93%) before going to 404 the public sector, compared to 67% in Kano. This might be because self-employed individuals 405 might be more flexible with the time required to seek, and the lower cost of public healthcare. 406 Two studies in India found young age, females, higher level of education and income group 407 associated with private sector use [65,66]. Several studies in Nigeria and other countries have 408 suggested that patients are reluctant to use the public sector because of longer waiting times, 409 lower quality of care, or poor provider attitudes, while on the contrary, private facilities have a 410 reputation of better quality at a higher cost [38,67,68]. 411 412 Patients who had difficulty in breathing as a symptom were more likely to use more than one 413 provider. Several studies have shown that patients with chest symptoms delay care-seeking for 414 a variety of reasons and also contact several private providers before diagnosis [69][70][71][72]. This is 415 likely because of the symptom minimization observed in several countries, where patients do 416 not immediately seek hospital care for cough until symptoms deteriorate, preferring to self-417 medicate, or visit informal providers [38,46,[72][73][74]. The use of more than one provider has also 418 been shown to be partly responsible for prolonged delays in TB diagnosis and treatment [5, 75-419 77]. 420 421 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 20, 2023. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 20, 2023. ; https://doi.org/10.1101/2023.06.13.23291334 doi: medRxiv preprint Tables and Figures   Fig 1 -Conceptual framework on types of delays along the TB care cascade [17,[31][32][33]  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 20, 2023.  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 20, 2023. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 20, 2023. ; https://doi.org/10.1101/2023.06.13.23291334 doi: medRxiv preprint  is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 20, 2023. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 20, 2023. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 20, 2023. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 20, 2023. ; https://doi.org/10.1101/2023.06.13.23291334 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 20, 2023. ; https://doi.org/10.1101/2023.06.13.23291334 doi: medRxiv preprint